WTO Public Forum: Trade Works – Taking Stock After 20 Years 28/09/2015 by Catherine Saez, Intellectual Property Watch Leave a Comment This week, the World Trade Organization is holding its yearly public forum with a focus on the contribution of the organisation to global trade since its inception 20 years ago. Some 90 sessions are planned, on issues such as intellectual property, global value chains, agriculture, trade for development, and the WTO dispute settlement system.
TTIP Could Lead To Jobs, Access To Better Drugs, Says Pharma 25/09/2015 by Marianna Drake for Intellectual Property Watch 1 Comment The trade negotiation between Europe and the United States relating to a wide range of trade and investment policies could lead to greater job creation and access to innovative medicines, according to senior European and American pharmaceutical business leaders and academics.
UN SDGs Need U-Turn On Governance For Health 24/09/2015 by Intellectual Property Watch 1 Comment The 2030 Agenda for Sustainable Development, to be adopted this week at UN Headquarters, could fall short of its health targets unless the governments embark on “U-turn” changes to rectify the dysfunctions in global governance that undermine health, writes Daniele Dionisio.
Are The UN And WIPO Drifting Apart? 23/09/2015 by William New, Intellectual Property Watch Leave a Comment NEW YORK – As some of the most powerful people on earth prepare to gather here later this week at the United Nations to discuss the biggest problems and opportunities facing humankind for the next 15 years, mention of a key issue underlying many themes – intellectual property – is hard to find. Also hard to find is reference to the UN agency responsible for the issue, the World Intellectual Property Organization.
Health Advocates Press United States On WTO LDC IP Waiver 18/09/2015 by Catherine Saez, Intellectual Property Watch 1 Comment Several leading public health groups have sent a letter to United States Trade Representative and US Patent and Trademark Office director asking for more transparency on the US position on a request by least-developed countries to indefinitely extend their World Trade Organization intellectual property waiver on pharmaceutical products.
The Lexmark Litigation: Why Does Big Pharma Care So Much About Ink Cartridges? 17/09/2015 by Intellectual Property Watch Leave a Comment The Federal Circuit will soon hear Lexmark v. Impression Products, a case about ink cartridges. Impression, a foreign buyer, refills spent Lexmark cartridges and resells them in the United States. Impression claims that Lexmark, having sold the cartridges, has exhausted its patent rights, and cannot hold Impression liable for patent infringement. The Federal Circuit will address whether the US patent is exhausted with the sale of the patented product outside the US, write Burcu Kilic and Peter Maybarduk.
European Commission Supports Indefinite Exemption Of LDCs From IPRs On Pharmaceuticals 10/09/2015 by Intellectual Property Watch 4 Comments In a communication today, the European Commission said it agrees to support a least developed country request at the World Trade Organization to prolong indefinitely a current exemption on the enforcement of IP on pharmaceutical products. Now the decision moves to the EU member states.
Neglected Diseases R&D Initiative To Expand Portfolio To Hepatitis C, New Antibiotics 09/09/2015 by Catherine Saez, Intellectual Property Watch Leave a Comment The Drugs for Neglected Diseases initiative (DNDi) is moving into new disease areas and has moved away from one, it announced this week.
Biopharmaceutical Industry Protests French Regime For Off-Label Products 08/09/2015 by Catherine Saez, Intellectual Property Watch Leave a Comment France is in the firing line of the biopharmaceutical industry for allowing the use of some products for other therapeutic indications than the one for which they obtained marketing authorisation.
Universal Health Coverage, Millennium Development Goals And Post-2015: The Improvable Way Forward 02/09/2015 by Intellectual Property Watch 1 Comment The negotiating process to achieve post-2015 development goals has clarified the agenda that governments ought to follow until 2030. Unfortunately, due to vague terms and the lack of unequivocal definitions, a number of relevant issues still lie in uncertainty, writes Pietro Dionisio